CYCLODX DIN 02462958
Status: Marketed
Holder: CIUSS DE L'ESTRIE - CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE
Molecule: FLUDEOXYGLUCOSE
Health Canada record
| Active ingredient(s) | FLUDEOXYGLUCOSE 18F 7.4 GBQ |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | V09IX04 FLUDEOXYGLUCOSE (18F) |
| Original market date | 01-May-2017 |
| Current status date | 04-Feb-2020 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUDEOXYGLUCOSE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02460734 | [F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION | SYLVIA FEDORUK CANADIAN CENTRE FOR NUCLEAR INNOVATION | Solution | FLUDEOXYGLUCOSE 18F 441 GBQ | Marketed |
| 02328739 | 18F-FLUDEOXYGLUCOSE (18F-FDG) | ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD. | Solution | FLUDEOXYGLUCOSE 18F 7400 MBq | Marketed |
| 02438380 | ATLANTISCAN | NOVA SCOTIA HEALTH AUTHORITY | Solution | FLUDEOXYGLUCOSE 18F 200 MCI | Marketed |
| 02433230 | FLUDEOXYGLUCOSE (18F) INJECTION | BC CANCER, PART OF THE PROVINCIAL HEALTH SERVICES AUTHORITY | Solution | FLUDEOXYGLUCOSE 18F 0.5 GBQ | Marketed |
| 02412837 | FLUDEOXYGLUCOSE (18F) INJECTION | SHARED HEALTH | Solution | FLUDEOXYGLUCOSE 18F 0.5 GBQ | Marketed |
| 02462354 | FLUDEOXYGLUCOSE (F-18) | LAWSON HEALTH RESEARCH INSTITUTE | Solution | FLUDEOXYGLUCOSE 18F 232 GBQ | Marketed |
| 02467151 | FLUDEOXYGLUCOSE [F-18] FDG INJECTION | THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE | Solution | FLUDEOXYGLUCOSE 18F 0.5 GBQ | Marketed |
| 02467178 | FLUDEOXYGLUCOSE [F-18] FDG INJECTION | THUNDER BAY REGIONAL HEALTH SCIENCES CENTRE | Solution | FLUDEOXYGLUCOSE 18F 0.5 GBQ | Approved |
| 02327740 | FLUGLUCOSCAN | ALBERTA HEALTH SERVICES | Solution | FLUDEOXYGLUCOSE 18F 0.5 GBQ | Marketed |
| 02328941 | CANTRACE | IPET PHARMACEUTICALS INC. | Solution | FLUDEOXYGLUCOSE 18F 732 MBq | Cancelled Pre Market |
| 02469839 | FLUDEOXYGLUCOSE F18 INJECTION | MONTREAL NEUROLOGICAL INSTITUTE | Solution | FLUDEOXYGLUCOSE 18F 7.4 MBq | Cancelled Pre Market |
| 02361388 | FLUOROHMET (CITRATE) | UNIVERSITY OF OTTAWA HEART INSTITUTE - NATIONAL CARDIAC PET CENTRE | Solution | FLUDEOXYGLUCOSE 18F 157 GBQ | Dormant |
| 02486601 | FLUOROHMET (PHOSPHATE) | UNIVERSITY OF OTTAWA HEART INSTITUTE - NATIONAL CARDIAC PET CENTRE | Solution | FLUDEOXYGLUCOSE 18F 157 GBQ | Dormant |
| 02328771 | GLUCOVISION (CITRATE) | CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION | Solution | FLUDEOXYGLUCOSE 18F 453 GBQ | Cancelled Post Market |
| 02486644 | GLUCOVISION (CITRATE) | CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION | Solution | FLUDEOXYGLUCOSE 18F 453 GBQ | Cancelled Post Market |
| 02486652 | GLUCOVISION (PHOSPHATE) | CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION | Solution | FLUDEOXYGLUCOSE 18F 540 GBQ | Cancelled Post Market |
| 02486660 | GLUCOVISION (PHOSPHATE) | CENTRE FOR PROBE DEVELOPMENT AND COMMERCIALIZATION | Solution | FLUDEOXYGLUCOSE 18F 540 GBQ | Cancelled Post Market |
| 02333163 | GLUDEF | ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD. | Solution | FLUDEOXYGLUCOSE 18F 232 GBQ | Cancelled Pre Market |
| 02333155 | GLUDEF | ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD. | Solution | FLUDEOXYGLUCOSE 18F 51.5 GBQ | Cancelled Pre Market |
International API supply for FLUDEOXYGLUCOSE
5 active FDA Drug Master Files.
Request a quote for CYCLODX